Medipharm acquires share in U.S. fermentation facility

by Emily Wilson
Share This:

ARHUS, DENMARK — Arla Foods of Arhus, Denmark, through its subsidiary Medipharm AB, Sweden, is to purchase Triple "F" Inc.’s 50% ownership in the Medipharm USA fermentation facility located in Des Moines, Iowa, U.S. In addition to the fermentation facility in Des Moines, Medipharm has production facilities in Czech Republic, Hungary, and Sweden with the home office located in Kågeröd, Sweden.

Medipharm USA is a basic producer of lactic acid bacteria. Its primary business in the U.S. is as a private label supplier of microbial products for feed, silage and hay inoculants and microbial gels. The sale will allow Triple "F" to focus on its core businesses of extrusion, oil pressing and oil refining technology through Insta-Pro International and animal nutrition through its PharmTech International Division.